SHELLY WRAY: Open Payments
NPI 1497273171 · DUMAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 31 payments from 6 companies in 2025. Trend: 2023 $29 · 2024 $597 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $247 |
| Axsome Therapeutics, Inc. | 11 | $242 |
| AstraZeneca Pharmaceuticals LP | 6 | $202 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Auvelity, BREZTRI, Ozempic, Rybelsus, AIRSUPRA, Wegovy, GVOKE HYPOPEN, UZEDY.
Industry payments across TX — which companies pay providers there.
